Serotonergic modulation of neuronal activity in the nucleus accumbens following repeated methamphetamine administration in rats

Journal of Pharmacological Sciences

Volumn 123, Issue 2, 2013, Pages 140-146

  Ishihara, Kumatoshi ^a   Takahashi, Naomichi ^a   Komoto, Naoki ^a   Yoshikawa, Chisato ^a   Fukumoto, Shuhei ^a   Ide, Soichiro ^a,b   Kimura, Takeshi ^c   Ozawa, Koichiro ^c  

^a HIROSHIMA INTERNATIONAL UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c HIROSHIMA UNIVERSITY   (Japan)

Author keywords

Adenylate cyclase; Methamphetamine; Nucleus accumbens; Population spike; Serotonin

Indexed keywords

ADENYLATE CYCLASE ACTIVATOR; BUCLADESINE; METHAMPHETAMINE; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN 3 RECEPTOR; SEROTONIN 4 RECEPTOR; SEROTONIN 6 RECEPTOR; SEROTONIN 7 RECEPTOR; SEROTONIN AGONIST; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN SLICE; CONTROLLED STUDY; ELECTROPHYSIOLOGICAL PROCEDURES; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; MALE; NEUROMODULATION; NONHUMAN; NUCLEUS ACCUMBENS; RAT; SECOND MESSENGER; SEROTONINERGIC MODULATION; SEROTONINERGIC SYSTEM; SIGNAL TRANSDUCTION; SYNAPSE; WISTAR RAT;

ADENYLATE CYCLASE; ANIMALS; ELECTROPHYSIOLOGICAL PHENOMENA; ENZYME ACTIVATORS; MALE; METHAMPHETAMINE; NEURAL INHIBITION; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SECOND MESSENGER SYSTEMS; SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN RECEPTOR AGONISTS; SIGNAL TRANSDUCTION; TIME FACTORS;

EID: 84888606424     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.13100FP     Document Type: Article

References (32)

1. Ago Y, Nakamura S, Baba A, Matsuda T. Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitzation in mice. J Pharmacol Sci. 2008;106:15-21.
2. Fleckenstain AE, Haughey HM, Metzger RR, Kokoshka JM, Riddle EL, Hanson JE, et al. Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function. Eur J Pharmacol. 1999;382:45-49.
3. Stahl SM. Disorders of reward, drug abuse, and their treatment. In: Stahl's essential psychopharmacology. Neuroscientific basis and practical applications. 3rd ed. New York: Cambridge University Press; 2008. p. 943-1011.
4. Akiyama K, Ujike H, Sakai K, Shimizu Y, Kodama M, Kuroda S. Effect of 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline on methamphetamine- and cocain-induced behavioral sensitization. Pharmacol Biohem and Behav. 1998;61:419-426.
5. Ujike H, Onoue T, Akiyama K, Hamamura T, Otsuki S. Effects of selective D-1 and D-2 dopamine antagonists on development of methamphetamine-induced behavioral sensitization. Psychopharmacol (Berl). 1989;98:89-92.
6. Kirby LG, Zeeb FD, Winstanley CA. Contribution of serotonin in addiction vulnerability. Neuropharmacol. 2011;61:421-432.
7. 3 receptors in drug abuse and as a target for pharmacotherapy. CNS Neurol Disord Drug Targets. 2008;7:454-467.
8. Ersche KD, Robbins TW. An integrated framework for human neuroimaging studies of addiction from a preclinical perspective. In: Adinoff B, Stein EA, editors. Neuroimaging in addiction. West Sussex: Wiley-Blackwell; 2011. p. 9-33.
9. Muramatsu M, Lapiz MDS, Tanaka E, Grenhoff J. Serotonin inhibits synaptic glutamate currents in rat nucleus accumbens neurons via presynaptic 5-HT1B receptors. Eur J Neurosci. 1998;10:2371-2379.
10. Buckby LE, Lacey MG. Depression of excitatory cortico-nucleus accumbens synaptic transmission in rat brain slices by dopamine, but not adenosine, depends upon intracortical mechanisms. Exp Brain Res. 2001;141:560-566.
11. 2 receptor in rat ventral tegmental area. Neurosci Lett. 2003;347:89-92.
12. Kimura T, Ishihara K, Ozawa K, Sasa M. Augmentation of serotonin-induced inhibition of neuronal activity in the hippocampus following repeated treatment with methamphetamine. Ann N Y Acad Sci. 2004;1025:242-247.
13. Brown P, Molliver ME. Dual serotonin (5-HT) projections to the nucleus accumbens core and shell: relation of the 5-HT transporter to amphetamine-induced neurotoxicity. J Neurosci. 2000;20:1952-1963.
14. 3 receptors in the nucleus accumbens in the potentiation of cocaine-induced behaviours in the rat. Br J Pharmacol. 2000;131:1294-1302.
15. Barnes NM, Sharp T. A review of central 5-HT receptors and their function. Neuropharmacol. 1999;38:1083-1152.
16. 4-receptor-mediated depolarization due to protein kinase A system in young rat hippocampal CA1 neurons. J Pharmacol Sci. 2004;95:329-334.
17. 4 receptor agonists, RS 67333 and RS67506, in vitro and in vivo. Br J Pharmacol. 1995;115:1387-1392.
18. 6 receptor agonists. Bioorga & Medici Chem Lett. 2005;15:4230-4234.
19. 7 receptor agonits AS 19 in an autoshaping learning task. Behav Brain Res. 2005;163:136-140.
20. 7 receptor agents. 2. J Med Chem. 2007;50:4214-4221.
21. O'Donnell P, Greene J, Pabello N, Lewis BL, Grace AA. Modulation of cell firing in the nucleus accumbens. Ann N Y Acad Sci. 1999;877:157-175.
22. Pennartz CMA, Boeijinga PH, Lopes da Silva FH. Locally evoked potentials in slices of the rat nucleus accumbens: NMDA and non-NMDA receptor mediated components and modulation by GABA. Brain Res. 1990;529:30-41.
23. 3H]mesulergine: comparison to other mammalian species. Br J Pharmacol. 2004;141:92-104.
24. 7 receptor in rat brain. Br J Pharmacol. 1996;117:657-666.
25. Hamblin MW, Guthrie CR, Kohen R, Heidmann DEA. Gs protein-coupled serotonin receptors: Receptor isoforms and functional differences. Ann N Y Acad Sci. 1998;861:31-37.
26. 7A receptor. J Biol Chem. 1998;273:17469-17476.
27. Uchiumi O, Kasahara Y, Fukui A, Hall FS, Uhl GR, Sora I. Serotonergic involvement in the amelioration of behavioral abnormalities in dopaminergic transporter knockout mice by nicotine. Neuropharmacol. 2013;64:348-356.
28. Yoshizawa K, Mori T, Ueno T, Nishiwaki M, Shibasaki M, Shimizu N, et al. Involvement of serotonin receptor mechanisms in the discriminative stimulus effects of ketamine in rats. J Pharmacol Sci. 2013;121:237-241.
29. Mcmahon LR, Cunningham KA. Antagonism of 5-hydroxytryptamine4 receptors attenuates hyperactivity induced by cocaine: putative role for 5-hydroxytryptamine4 receptors in the nucleus accumbens shell. J Pharmacol and Exp Ther. 1999;291:300-307.
30. Kaneko Y, Sashiwa A, Ito T, Ishii S, Umino A, Nishikawa T. Selective serotonin reuptake inhibitors, fluoxetine and paroxetine, attenuate the expression of the established behavioral sensitization induced by methamphetamine. Neuropsychopharmacology. 2007;32:658-664.
31. Yamamoto H, Tanaka S, Tanaka A, Hide I, Seki T, Sakai N. Long-term exposure of RN46A cells expressing serotonin transporter (SERT) to a cAMP analog up-regulates SERT activity and is accompanied by neural differentiation of the cells. J Pharmacol Sci. 2013;121:25-38.
32. Gorentla BK, Moritz AE, Foster JD, Vaughan RA. Proline-directed phosphorylation of the dopamine transporter N-terminal domain. Biochemistry. 2009;48:1067-1076.